-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Lyell Immunopharma, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q2 2025.
- Lyell Immunopharma, Inc. Return On Equity for the quarter ending June 30, 2025 was -85.6 %, a 157% decline year-over-year.
- Lyell Immunopharma, Inc. annual Return On Equity for 2024 was -65.9 %, a 102% decline from 2023.
- Lyell Immunopharma, Inc. annual Return On Equity for 2023 was -32.7 %, a 51.7% decline from 2022.
- Lyell Immunopharma, Inc. annual Return On Equity for 2022 was -21.5 %, a 44% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)